Ducho, Christian

[["dc.bibliographiccitation.firstpage","15292"],["dc.bibliographiccitation.issue","47"],["dc.bibliographiccitation.journal","Chemistry - A European Journal"],["dc.bibliographiccitation.lastpage","15297"],["dc.bibliographiccitation.volume","20"],["dc.contributor.author","Spork, Anatol P."],["dc.contributor.author","Bueschleb, Martin"],["dc.contributor.author","Ries, Oliver"],["dc.contributor.author","Wiegmann, Daniel"],["dc.contributor.author","Boettcher, Stefan"],["dc.contributor.author","Mihalyi, Agnes"],["dc.contributor.author","Bugg, Timothy D. H."],["dc.contributor.author","Ducho, Christian"],["dc.date.accessioned","2018-11-07T09:32:36Z"],["dc.date.available","2018-11-07T09:32:36Z"],["dc.date.issued","2014"],["dc.description.abstract","Naturally occurring muraymycin nucleoside antibiotics represent a promising class of novel antibacterial agents. The structural complexity suggests the investigation of simplified analogues as potential lead structures, which can then be further optimized towards highly potent antimicrobials. Herein we report studies on muraymycin-derived potential lead structures lacking an aminoribose motif found in most naturally occurring muraymycins. We have identified a 5'-defunctionalized motif to be ideal in terms of stability and chemical accessibility and have synthesized a full-length muraymycin analogue based on this structure using a novel fully stereocontrolled route. The obtained 5'-deoxy analogue of the natural product muraymycin C4 showed good inhibitory properties towards the bacterial target protein MraY, sufficient pharmacokinetic stability and no cytotoxicity against human cells, thus making it a promising lead for antibacterial drug development."],["dc.identifier.doi","10.1002/chem.201404775"],["dc.identifier.isi","000345234800002"],["dc.identifier.pmid","25318977"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/31787"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Wiley-v C H Verlag Gmbh"],["dc.relation.issn","1521-3765"],["dc.relation.issn","0947-6539"],["dc.title","Lead Structures for New Antibacterials: Stereocontrolled Synthesis of a Bioactive Muraymycin Analogue"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]

[["dc.bibliographiccitation.firstpage","208"],["dc.bibliographiccitation.issue","1"],["dc.bibliographiccitation.journal","Tetrahedron"],["dc.bibliographiccitation.lastpage","214"],["dc.bibliographiccitation.volume","66"],["dc.contributor.author","Lemke, Anke"],["dc.contributor.author","Bueschleb, Martin"],["dc.contributor.author","Ducho, Christian"],["dc.date.accessioned","2018-11-07T08:46:49Z"],["dc.date.available","2018-11-07T08:46:49Z"],["dc.date.issued","2010"],["dc.description.abstract","The hydroxylated amino acid 3-hydroxy-L-arginine is an intermediate in the biosynthesis of the non-proteinogenic amino acid capreomycidine and possibly also of its epimer epicapreomycidine. The novel concise synthesis of 3-hydroxy-L-arginine presented here allows the efficient preparation of both 3-epimers of this beta-hydroxy amino acid. It also offers the potential to obtain suitably isotope-labelled derivatives for the elucidation of epicapreomycidine assembly in the biosynthesis of complex natural products. (C) 2009 Elsevier Ltd. All rights reserved."],["dc.description.sponsorship","Fonds der Chemischen Industrie (FCI)"],["dc.identifier.doi","10.1016/j.tet.2009.10.102"],["dc.identifier.isi","000273066200022"],["dc.identifier.uri","https://resolver.sub.uni-goettingen.de/purl?gro-2/20789"],["dc.notes.status","zu prüfen"],["dc.notes.submitter","Najko"],["dc.publisher","Pergamon-elsevier Science Ltd"],["dc.relation.issn","0040-4020"],["dc.title","Concise synthesis of both diastereomers of 3-hydroxy-L-arginine"],["dc.type","journal_article"],["dc.type.internalPublication","yes"],["dc.type.peerReviewed","yes"],["dc.type.status","published"],["dspace.entity.type","Publication"]]